Receptos: Receptos Downgraded to "Sell" at Zacks (RCPT)

Zacks cut shares of Receptos (NASDAQ:RCPT) from a hold rating to a sell rating in a report issued on Thursday morning, Analyst Ratings Net reports. According to Zacks, "Receptos, Inc. is a biopharmaceutical company. It develops therapeutic for the treatment of immune and metabolic diseases. Receptos, Inc. is headquartered in San Diego, California. " In [...]